Literature DB >> 22714135

Patients with migraine do not have MRI-visible cortical lesions.

Martina Absinta1, Maria A Rocca, Bruno Colombo, Massimiliano Copetti, Donatella De Feo, Andrea Falini, Giancarlo Comi, Massimo Filippi.   

Abstract

Migraine patients with multiple brain white matter hyperintensities (WMHs) may represent a diagnostic challenge. Using double inversion recovery (DIR) imaging, we studied whether cortical lesions (CLs) could be seen in these patients. Approval of the institutional review boards and written informed consent were obtained from each participant. CLs and WM lesions were assessed on brain scans from 32 migraine patients with WMHs (17 patients with and 15 without aura), and in two control groups, consisting of 15 relapsing-remitting multiple sclerosis (RRMS) patients and 20 healthy controls, matched for age and gender. By definition, brain WM lesions were detected in all migraine and RRMS patients. The number and volume of WM lesions were lower in migraine versus RRMS patients (p < 0.0001). No CLs were identified in migraine patients and healthy controls, whereas 20 CLs were seen in 9 (60 %) RRMS patients. The application of DIR imaging to assess focal cortical involvement seems to be useful in the diagnostic workup of patients with WMHs of unknown etiology, including those with migraine.

Entities:  

Mesh:

Year:  2012        PMID: 22714135     DOI: 10.1007/s00415-012-6571-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

Authors:  M Filippi; M A Rocca; M Calabrese; M P Sormani; F Rinaldi; P Perini; G Comi; P Gallo
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

Review 3.  The role of the clinician in interpreting conventional neuroimaging findings in migraine patients.

Authors:  F Moschiano; D D'Amico; M Di Stefano; N Rocca; G Bussone
Journal:  Neurol Sci       Date:  2007-05       Impact factor: 3.307

4.  Double inversion recovery imaging of the brain: initial experience and comparison with fluid attenuated inversion recovery imaging.

Authors:  K Turetschek; P Wunderbaldinger; A A Bankier; T Zontsich; O Graf; R Mallek; K Hittmair
Journal:  Magn Reson Imaging       Date:  1998       Impact factor: 2.546

Review 5.  Cortical lesions in multiple sclerosis.

Authors:  Massimiliano Calabrese; Massimo Filippi; Paolo Gallo
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

6.  Dual inversion recovery MRI helps identifying cortical tubers in tuberous sclerosis.

Authors:  Francois Cotton; Loic Rambaud; Marc Hermier
Journal:  Epilepsia       Date:  2006-06       Impact factor: 5.864

7.  The prevalence of cerebral damage varies with migraine type: a MRI study.

Authors:  F Fazekas; M Koch; R Schmidt; H Offenbacher; F Payer; W Freidl; H Lechner
Journal:  Headache       Date:  1992-06       Impact factor: 5.887

8.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Imaging the neocortex in epilepsy with double inversion recovery imaging.

Authors:  Fergus J Rugg-Gunn; Philip A Boulby; Mark R Symms; Gareth J Barker; John S Duncan
Journal:  Neuroimage       Date:  2006-02-07       Impact factor: 6.556

View more
  14 in total

1.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

Review 2.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

3.  Brain MRI in patients affected by migraine with aura: is there any cortical lesion?

Authors:  Katia Khouri Chalouhi; Silvia Squarza; Anna Pisani Mainini; Paola Di Fiore; Maurizio Cariati; Fabio Frediani; Carla Uggetti
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 4.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

Review 5.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

6.  Reducing costs while enhancing quality of care in MS.

Authors:  Ilya Kister; John R Corboy
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

Review 7.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

8.  The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Authors:  Mario Tranfa; Mario Tortora; Giuseppe Pontillo; Valentina Iuzzolino; Eleonora Riccio; Simona Caccavallo; Teodolinda Di Risi; Serena Monti; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Palma; Maria Petracca; Antonio Pisani; Arturo Brunetti; Sirio Cocozza
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 5.315

Review 9.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

10.  Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.

Authors:  Elliot Graziano; Jesper Hagemeier; Bianca Weinstock-Guttman; Deepa P Ramasamy; Robert Zivadinov
Journal:  Neuroimage Clin       Date:  2015-08-01       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.